396
Views
1
CrossRef citations to date
0
Altmetric
Wellbeing in Long Term Care

Psychotropic drug use in residents with dementia living in small-scaled special care facilities; a longitudinal study

ORCID Icon, &
Pages 689-696 | Received 11 Jul 2018, Accepted 12 Feb 2019, Published online: 05 Mar 2019

References

  • Allers, K., Dörks, M., Schmiemann, G., & Hoffmann, F. (2017). Antipsychotic drug use in nursing home residents with and without dementia: Keep an eye on the pro re nata medication. International Clinical Psychopharmacology, 32(4), 213–218.
  • Ausserhofer, D., Deschodt, M., De Geest, S., van Achterberg, T., Meyer, G., Verbeek, H., … Engberg, S. (2016). “There’s no place like home”: A scoping review on the impact of homelike residential care models on resident-, family-, and staff-related outcomes. Journal of the American Medical Directors Association, 17(8), 685–693.
  • Axmon, A., Kristensson, J., Ahlström, G., & Midlöv, P. (2017). Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia. Research in Developmental Disabilities, 62, 50–57.
  • Birkenhäger-Gillesse, E. G., Kollen, B. J., Achterberg, W. P., Boersma, F., Jongman, L., & Zuidema, S. U. (2018). Effects of psychosocial interventions for behavioral and psychological symptoms in dementia on the prescription of psychotropic drugs: A systematic review and meta-analyses. Journal of the American Medical Directors Association, 19(3), 276.e1–276.e9.
  • Bjerre, L. M., Farrell, B., Hogel, M., Graham, L., Lemay, G., McCarthy, L., … Wiens, A. (2018). Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Canadian Family Physician Medecin de Famille Canadien, 64(1), 17–27.
  • Bogetti-Salazar, M., González-González, C., Juárez-Cedillo, T., Sánchez-García, S., & Rosas-Carrasco, O. (2016). Severe potential drug-drug interactions in older adults with dementia and associated factors. Clinics (Sao Paulo), 71(1), 17–21.
  • Bonner, A. F., Field, T. S., Lemay, C. A., Mazor, K. M., Andersen, D. A., Compher, C. J., … Gurwitz, J. H. (2015). Rationales that providers and family members cited for the use of antipsychotic medications in nursing home residents with dementia. Journal of the American Geriatrics Society, 63(2), 302–308.
  • Cadigan, R. O., Grabowski, D. C., Givens, J. L., & Mitchell, S. L. (2012). The quality of advanced dementia care in the nursing home: The role of special care units. Medical Care, 50(10), 856–862.
  • Davies, E. A., & O'Mahony, M. S. (2015). Adverse drug reactions in special populations – The elderly. British Journal of Clinical Pharmacology, 80(4), 796–807.
  • Dutcher, S. K., Rattinger, G. B., Langenberg, P., Chhabra, P. T., Liu, X., Rosenberg, P. B., … Zuckerman, I. H. (2014). Effect of medications on physical function and cognition in nursing home residents with dementia. Journal of the American Geriatrics Society, 62(6), 1046–1055. doi:10.1111/jgs.12838
  • Eefsting, J., Boersma, F., van Tilburg, W., & van den Brink, W. (1997). Usefulness of the ‘Mini-Mental State Test’ for the diagnosis of dementia; study of criterion validity in a Dutch rural population. Nederlands Tijdschrift voor Geneeskunde, 141(43), 2066–2070.
  • Eggermont, L. H., de Vries, K., & Scherder, E. J. (2009). Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia. International Psychogeriatrics, 21(02), 286–294.
  • Erdal, A., Flo, E., Aarsland, D., Ballard, C., Slettebo, D. D., & Husebo, B. S. (2018). Efficacy and safety of analgesic treatment for depression in people with advanced dementia: Randomised, multicentre, double-blind, placebo-controlled trial (DEP.PAIN.DEM). Drugs & Aging, 35(6), 545–558.
  • Folstein, M., Folstein, S., & McHugh, P. (1975). Mini-Mental State: A practical method for grading the cognitive state of patients for de clinician. Journal of Psychiatric Research, 12(3), 189–198.
  • Gale, S. A., Acar, D., & Daffner, K. R. (2018). Dementia. The American Journal of Medicine, 131(10), 1161–1169.
  • Gardette, V., Lapeyre-Mestre, M., Coley, N., Cantet, C., Montastruc, J. L., Vellas, B., & Andrieu, S. (2012). Antipsychotic use and mortality risk in community-dwelling Alzheimer’s disease patients: Evidence for a role of dementia severity. Current Alzheimer Research, 9(9), 1106–1116.
  • Gareri, P., De Fazio, P., Manfredi, V. G., & De Sarro, G. (2014). Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. Journal of Clinical Psychopharmacology, 34(1), 109–123.
  • Gauthier, S., Cummings, J., Ballard, C., Brodaty, H., Grossberg, G., Robert, P., & Lyketsos, C. (2010). Management of behavioral problems in Alzheimer’s disease. International Psychogeriatrics, 22(03), 346–372.
  • Gerlach, L. B., & Kales, H. C. (2018). Managing behavioral and psychological symptoms of dementia. Psychiatric Clinics of North America, 41(1), 127–139.
  • Gruneir, A., Lapane, K. L., Miller, S. C., & Mor, V. (2008). Does the presence of a dementia special care unit improve nursing home quality? Journal of Aging and Health, 20(7), 837–854.
  • Haaksma, M. L., Vilela, L. R., Marengoni, A., Calderón-Larrañaga, A., Leoutsakos, J. S., Olde Rikkert, M. G. M., & Melis, R. J. F. (2017). Comorbidity and progression of late onset Alzheimer’s disease: A systematic review. PLoS One, 12(5), e0177044.
  • Haddad, K. E., de Souto Barreto, P., Gerard, S., Prouff, A., Vellas, B., & Rolland, Y. (2018). Effect of relocation on neuropsychiatric symptoms in elderly adults living in long-term care. Journal of the American Geriatrics Society, 66(11), 2183–2187.
  • Ham, A. C., Swart, K. M., Enneman, A. W., van Dijk, S. C., Oliai Araghi, S., van Wijngaarden, J. P., … van der Velde, N. (2014). Medication-related fall incidents in an older, ambulant population: The B-PROOF study. Drugs & Aging, 31(12), 917–927.
  • Hort, J., O’Brien, J. T., Gainotti, G., Pirttila, T., Popescu, B. O., Rektorova, I., … Scheltens, P; EFNS Scientist Panel on Dementia. (2010). EFNS guidelines for the diagnosis and management of Alzheimer’s disease. European Journal of Neurology, 17(10), 1236–1248.
  • Huybrechts, K. F., Gerhard, T., Crystal, S., Olfson, M., Avorn, J., Levin, R., … Schneeweiss, S. (2012). Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: Population based cohort study. BMJ, 344(2), e977.
  • Ivanova, I., Wauters, M., Stichele, R. V., Christiaens, T., De Wolf, J., Dilles, T., & Elseviers, M. (2018). Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health. Archives of Gerontology and Geriatrics, 75, 202–208.
  • Janus, S. I., van Manen, J. G., IJzerman, M. J., & Zuidema, S. U. (2016). Psychotropic drug prescriptions in Western European nursing homes. International Psychogeriatrics, 28(11), 1775–1790.
  • Kim, D. H., Brown, R. T., Ding, E. L., Kiel, D. P., & Berry, S. D. (2011). Dementia medications and risk of falls, syncope, and related adverse events: Meta-analysis of randomized controlled trials. Journal of the American Geriatrics Society, 59(6), 1019–1031.
  • Kohen, I., Lester, P. E., & Lam, S. (2010). Antipsychotic treatments for the elderly: Efficacy and safety of aripiprazole. Neuropsychiatric Disease and Treatment, 6, 47–58.
  • Kok, J. S., Berg, I. J., & Scherder, E. J. (2013). Special care units and traditional care in dementia: Relationship with behavior, cognition, functional status and quality of life – A review. Dementia and Geriatric Cognitive Disorders Extra, 3(1), 360–375.
  • Kok, J. S., Berg, I. J., Blankevoort, G. C. G., & Scherder, E. J. A. (2017). Rest-activity rhythms in small scale homelike care and traditional care for residents with dementia. BMC Geriatrics, 17(1), 137.
  • Kok, J. S., Nielen, M. M. A., & Scherder, E. J. A. (2018). Quality of life in small-scaled homelike nursing homes: An 8-month controlled trial. Health and Quality of Life Outcomes, 16(1), 38.
  • Kok, J. S., van Heuvelen, M. J., Berg, I. J., & Scherder, E. J. (2016). Small scale homelike special care units and traditional special care units: Effects on cognition in dementia; a longitudinal controlled intervention study. BMC Geriatrics, 16, 47.
  • Kosse, N. M., de Groot, M. H., Vuillerme, N., Hortobágyi, T., & Lamoth, C. J. (2015). Factors related to the high fall rate in long-term care residents with dementia. International Psychogeriatrics, 27(05), 803–814.
  • Kröger, E., Wilchesky, M., Marcotte, M., Voyer, P., Morin, M., Champoux, N., … Arcand, M. (2015). Medication use among nursing home residents with severe dementia: Identifying categories of appropriateness and elements of a successful intervention. Journal of the American Medical Directors Association, 16(7), 629.e1–e7.
  • Lai, C. K., Yeung, J. H., Mok, V., & Chi, I. (2009). Special care units for dementia individuals with behavioural problems. Cochrane Database of Systematic Reviews, 4, CD006470.
  • Lee, J., Jung, S. J., Choi, J. W., Shin, A., & Lee, Y. J. (2018). Use of sedative-hypnotics and the risk of Alzheimer’s dementia: A retrospective cohort study. PLoS One, 13(9), e0204413.
  • Legere, L. E., McNeill, S., Martin, L. S., Acorn, M., & An, D. (2018). Non-pharmacological approaches for behavioural and psychological symptoms of dementia in older adults: A systematic review of reviews. Journal of Clinical Nursing, 27(7-8), e1360–e1376.
  • Linjakumpu, T., Hartikainen, S., Klaukka, T., Koponen, H., Kivela, S. L., & Isoaho, R. (2003). A model to classify the sedative load of drugs. International Journal of Geriatric Psychiatry, 18(6), 542–544.
  • Lukas, A., Mayer, B., Fialová, D., Topinkova, E., Gindin, J., Onder, G., … Denkinger, M. D. (2013). Pain characteristics and pain control in European nursing homes: Cross-sectional and longitudinal results from the Services and Health for Elderly in Long TERm care (SHELTER) study. Journal of the American Medical Directors Association, 14(6), 421–428.
  • Madhusoodanan, S., & Shah, P. (2008). Management of psychosis in patients with Alzheimer’s disease: Focus on aripiprazole. Clinical Interventions in Aging, 3(3), 491–501.
  • Masopust, J., Protopopová, D., Vališ, M., Pavelek, Z., & Klímová, B. (2018). Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: A review. Neuropsychiatric Disease and Treatment, 14, 1211–1220.
  • McGrattan, M., Ryan, C., Barry, H. E., & Hughes, C. M. (2017). Interventions to improve medicines management for people with dementia: A systematic review. Drugs & Aging, 34(12), 907–916.
  • McMaster, M., Fielding, E., Lim, D., Moyle, W., & Beattie, E., & AusQoL Group. (2017). A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: Issues of concern. International Psychogeriatrics, 4, 1–8.
  • Meeks, T. W., & Jeste, D. V. (2008). Beyond the black box: What is the role for antipsychotics in dementia? Current Psychiatry, 7(6), 50–65.
  • Molloy, D., Alemayehu, E., & Roberts, R. (1991). Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. The American Journal of Psychiatry, 148(1), 102–105.
  • Niu, H., Álvarez-Álvarez, I., Guillén-Grima, F., & Aguinaga-Ontoso, I. (2017). Prevalence and incidence of Alzheimer’s disease in Europe: A meta-analysis. Neurologia, 32(8), 523–532.
  • Onder, G., Carpenter, I., Finne-Soveri, H., Gindin, J., Frijters, D., Henrard, J. C., … Bernabei, R. (2012). Assessment of nursing home residents in Europe: The Services and Health for Elderly in Long TERm care (SHELTER) study. BMC Health Services Research, 12, 5.
  • Parsons, C. (2017). Polypharmacy and inappropriate medication use in patients with dementia: An underresearched problem. Therapeutic Advances in Drug Safety, 8(1), 31–46.
  • Pasqualetti, G., Tognini, S., Calsolaro, V., Polini, A., & Monzani, F. (2015). Potential drug-drug interactions in Alzheimer patients with behavioral symptoms. Clinical Interventions in Aging, 10, 1457–1466.
  • Picton, J. D., Marino, A. B., & Nealy, K. L. (2018). Benzodiazepine use and cognitive decline in the elderly. American Journal of Health-System Pharmacy, 75(1), e6–e12.
  • Prentice, A., & Wright, D. (2014 ). Reducing antipsychotic drugs in care homes. Nursing Times, 110(22), 12–15.
  • Ralph, S. J., & Espinet, A. J. (2017). Use of antipsychotics and benzodiazepines for dementia: Time for action? What will be required before global de-prescribing? Dementia (London).
  • Richter, T., Meyer, G., Möhler, R., & Köpke, S. (2012). Psychosocial interventions for reducing antipsychotic medication in care home residents. Cochrane Database of Systematic Reviews, 12 CD008634.
  • Robey, R. (2004). Reporting point and interval estimates of effect-size for planned contrasts: Fixed within effect analyses of variance. Journal of Fluency Disorders, 29(4), 307–341.
  • Roen, I., Kirkevold, O., Testad, I., Selbaek, G., Engedal, K., & Bergh, S. (2017). Person-centered care in Norwegian nursing homes and its relation to organizational factors and staff characteristics: A cross-sectional survey. International Psychogeriatrics, 30(9), 1279–1290.
  • Ronning, M., Blix, H. S., Harbø, B. T., & Strøm, H. (2000). Different versions of the anatomical therapeutic chemical classification system and the defined daily dose – Are drug utilisation data comparable? European Journal of Clinical Pharmacology, 56(9-10), 723–727.
  • Rostad, H. M., Puts, M. T. E., Cvancarova Småstuen, M., Grov, E. K., Utne, I., & Halvorsrud, L. (2017). Associations between pain and quality of life in severe dementia: A Norwegian cross-sectional study. Dementia and Geriatric Cognitive Disorders Extra, 7(1), 109–121.
  • Scales, K., Zimmerman, S., & Miller, S. J. (2018). Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia. The Gerontologist, 58(suppl_1), S88–S102.
  • Shah, S. M., Carey, I. M., Harris, T., DeWilde, S., & Cook, D. G. (2011). Antipsychotic prescribing to older people living in care homes and the community in England and Wales. International Journal of Geriatric Psychiatry , 26(4), 423–434.
  • Sloane, P., Ivey, J., Roth, M., Roederer, M., & Williams, C. S. (2008). Accounting for the sedative and analgesic effects of medication changes during patient participation in clinical research studies: Measurement development and application to a sample of institutionalized geriatric patients. Contemporary Clinical Trials, 29(2), 140–148.
  • Smeets, C. H. W., Gerritsen, D. L., Zuidema, S. U., Teerenstra, S., van der Spek, K., Smalbrugge, M., & Koopmans, R. T. C. M. (2017). Psychotropic drug prescription for nursing home residents with dementia: Prevalence and associations with non-resident-related factors. Aging & Mental Health, 22, 1239–1246.
  • Tampi, R. R., Hassell, C., Joshi, P., & Tampi, D. J. (2017). Analgesics in the management of behavioral and psychological symptoms of dementia: A perspective review. Drugs in Context, 6, 1.
  • Tible, O. P., Riese, F., Savaskan, E., & von Gunten, A. (2017). Best practice in the management of behavioural and psychological symptoms of dementia. Therapeutic Advances in Neurological Disorders, 10(8), 297–309.
  • Toot, S., Swinson, T., Devine, M., Challis, D., & Orrell, M. (2017). Causes of nursing home placement for older people with dementia: A systematic review and meta-analysis. International Psychogeriatrics, 29(02), 195–208.
  • van der Putten, M. J., Wetzels, R. B., Bor, H., Zuidema, S. U., & Koopmans, R. T. (2014). Antipsychotic drug prescription rates among Dutch nursing homes: The influence of patient characteristics and the dementia special care unit. Aging & Mental Health, 18(7), 828–832.
  • van Strien, A. M., Koek, H. L., van Marum, R. J., & Emmelot-Vonk, M. H. (2013). Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly. Maturitas, 74(4), 357–362.
  • Verbeek, H., van Rossum, E., Zwakhalen, S. M., Ambergen, T., Kempen, G. I., & Hamers, J. P. (2009). The effects of small-scale, homelike facilities for older people with dementia on residents, family caregivers and staff: Design of a longitudinal, quasi-experimental study. BMC Geriatrics, 9, 3.
  • Verbeek, H., Zwakhalen, S. M., van Rossum, E., Ambergen, T., Kempen, G. I., & Hamers, J. P. (2010). Small-scale, homelike facilities versus regular psychogeriatric nursing home wards: A cross-sectional study into residents’ characteristics. BMC Health Services Research, 10, 30.
  • Verhage, F. (1964). Intelligence and age: Research on Dutch people aged twelve to seventy seven years old. Assen, The Netherlands: van Gorcum.
  • Vigen, C. L., Mack, W. J., Keefe, R. S., Sano, M., Sultzer, D. L., Stroup, T. S., … Schneider, L. S. (2011). Cognitive effects of atypical antipsychotic medications in patients with Alzheimer’s disease: Outcomes from CATIE-AD. American Journal of Psychiatry, 168(8), 831–839.
  • Vigen, R., Maddox, T. M., & Allen, L. A. (2012). Aging of the United States population: Impact on heart failure. Current Heart Failure Reports, 9(4), 369–374.
  • Walsh, K. A., O'Regan, N. A., Byrne, S., Browne, J., Meagher, D. J., & Timmons, S. (2016). Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: The influence of dementia on prescribing. International Psychogeriatrics, 28(11), 1807–1820.
  • Wang, Y. C., Tai, P. A., Poly, T. N., Islam, M. M., Yang, H. C., Wu, C. C., & Li, Y. J. (2018). Increased risk of dementia in patients with antidepressants: A meta-analysis of observational studies. Behavioural Neurology, 2018, 1.
  • WHO Collaborating Centre for Drug Statistics and Methodology (WHOCC). (2016, January). Guidelines for ATC Classification and DDD Assignment, 19th edition. Retrieved from http://www.whocc.no/filearchive/publications/2016_guidelines_web.pdf
  • Zuidema, S. U., de Jonghe, J. F., Verhey, F. R., & Koopmans, R. T. (2010). Environmental correlates of neuropsychiatric symptoms in nursing home patients with dementia. International Journal of Geriatric Psychiatry, 25(1), 14–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.